EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

Shengnan Zhang, Taiqiang Ye iD, Yibin Liu, Guige Hou, Qibao Wang, Fenglan Zhao, Feng Li, Qingguo Meng

Molecules · 10.11.2023 · 28 (22) · 7517

DOI: 10.3390/molecules28227517 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 10.11.2023. Verfasst von Shengnan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Pharmacology and Drug Evaluation (Ministry of Education), Collaborative Innovation Center of Advanced Drug Delivery Syste…. Hauptthemen laut MEDLINE: Paclitaxel, Taxus. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paclitaxel, a natural secondary metabolite isolated and purified from the bark of the Taxus tree, is considered one of the most successful natural anticancer drugs due to its low toxicity, high potency and broad-spectrum anticancer activity. Taxus trees are scarce and slow-growing, and with extremely low paclitaxel content, the contradiction between supply and demand in the market is becoming more and more intense. Therefore, researchers have tried to obtain paclitaxel by various methods such as chemical synthesis, artificial culture, microbial fermentation and tissue cell culture to meet the clinical demand for this drug. This paper provides a comprehensive overview of paclitaxel extraction, combination therapy, total synthesis, semi-synthesis and biosynthesis in recent years and provides an outlook, aiming to provide a theoretical basis and reference for further research on the production and application of paclitaxel in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PaclitaxelTaxusFermentation

Stichwörter der Autor:innen

anticancer mechanismbiosynthesispaclitaxelsemi-synthesistotal synthesis

Substanzen

Paclitaxel

Autor:innen und Institutionen

  • Key Laboratory of Molecular Pharmacology and Drug Evaluation (Ministry of Education), Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, School of Pharmacy, Y…
  • School of Pharmacy, Binzhou Medical University, Yantai 264003, China.
  • School of Biological Science, Jining Medical University, Rizhao 276800, China.

ORCID-Profile: Taiqiang Ye

Förderung

  • Shandong Provincial Natural Science Foundation, China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, S., Ye, T., Liu, Y., Hou, G., Wang, Q., Zhao, F., Li, F., & Meng, Q. (2023). Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel. Molecules, 28(22), 7517. https://doi.org/10.3390/molecules28227517

Vancouver

Zhang S, Ye T, Liu Y, Hou G, Wang Q, Zhao F, et al. Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel. Molecules. 2023;28(22):7517. doi:10.3390/molecules28227517

BibTeX
@article{Zhang2023,
  author = {Zhang, Shengnan and Ye, Taiqiang and Liu, Yibin and Hou, Guige and Wang, Qibao and Zhao, Fenglan and Li, Feng and Meng, Qingguo},
  title = {Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {22},
  pages = {7517},
  doi = {10.3390/molecules28227517}
}
Kostenlos starten →